![NEURAURA Biotech Inc.](https://static.wixstatic.com/media/11062b_76c0ea20f8624289a785e1a971cd205f~mv2.jpeg/v1/fill/w_980,h_654,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Laboratory%20Scientist.jpeg)
![Branding Colours LoOoP by Neuraura](https://static.wixstatic.com/media/4ccef1_b5c30a690f90435399cee9609c2ce17a~mv2.jpg/v1/fill/w_980,h_980,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/4ccef1_b5c30a690f90435399cee9609c2ce17a~mv2.jpg)
About Us
Our vision is to transform the standard of care for chronic, underserved health conditions. Starting with PCOS.
Our Founders
Neuraura is a neurotechnology company based out of Calgary, Canada.
Neuraura’s co-founders, Claire and Pierre, are dedicated to unlocking the potential of neurotechnology to transform lives
Our team is committed to closing gaps in health equity; we leverage our patented technology, leading edge research and the power of our global network.
![](https://static.wixstatic.com/media/4ccef1_abb68bad81fc425a95a89789d8a5100d~mv2.jpg/v1/fill/w_980,h_987,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Claire_CED%20Headshot.jpg)
Claire Dixon
Claire helped co-found Neuraura in 2017 and is passionate in her mission to close the health equity gap.
She has 25+ years’ international leadership, strategy, and operational experience, an MBA from Harvard Business School, and a MEng/MA (Cantab.) in Mechanical Engineering from Cambridge University.
Claire was recently named one of the Top 200 Trailblazing Leaders in Women’s Health and FemTech by Women of Wearables.
![](https://static.wixstatic.com/media/4ccef1_aa0646329af54e21afff6ecdb8e6c872~mv2.jpg/v1/fill/w_980,h_1225,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Pierre_headshot.jpg)
Pierre Wijdenes
Pierre has always dreamed of leveraging innovation in healthcare to make a difference in the lives of those with complex, chronic disorders.
He completed his Doctorate in Biomedical Engineering at the University of Calgary in 2017 and also holds a MEng/MSc in Human Factors, Cognitive Engineering, and User Interaction from the École Nationale Supérieure de Cognitique (“ENSC”) in Bordeaux - France.
“I’m driven to make a difference because of my own 8-year journey with infertility and pregnancy loss as well as the stories I hear every day from individuals carrying the burden of this complex and profound condition.” - Claire Dixon
![Gradient Background_edited_edited.jpg](https://static.wixstatic.com/media/4ccef1_c495e1088f254206a125b5f9119d9aa1~mv2.jpg/v1/fill/w_100,h_100,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/4ccef1_c495e1088f254206a125b5f9119d9aa1~mv2.jpg)
![](https://static.wixstatic.com/media/4ccef1_4bc262a9d2014575b3ee733e653d847d~mv2.png/v1/fill/w_297,h_264,al_c,q_85,enc_auto/Topaz.png)
Topaz Conway
Board Director
Topaz is a veteran of the innovation ecosystem with experience spanning MedTech, Bioengineering, IT and e- commerce. In addition to being Co-Founder/Chair of SBE Australia (an accelerator for women-led companies delivering the world class Springboard Accelerator) 2012-2018, Topaz is a Director of Cicada Innovations (New South Wales’ Deep-Tech incubator), Omni Tanker Pty Ltd, University of Technology (Sydney) Foundation and is Prof of Practice at UNSW School of Business Management. She served on the Advisory Council to the Minister of Research & Innovation in Alberta, Canada (ARIAC) until 2019, and was a Commercialisation Advisor to Australian government Accelerating Commercialisation Grant Program. She is past Chair of CleanSpace Technologies (ASX: CSX) a respiratory protection device company, and currently is an active investor, advisor and mentor.
![](https://static.wixstatic.com/media/4ccef1_0dcf3b14a75f4d8390ae8faab35f2a7b~mv2.png/v1/fill/w_277,h_243,al_c,q_85,enc_auto/Monty.png)
Monty Carter
Board Observer
Monty is the Board Chair and General Manager of TECTERRA, a government-funded non-profit organization that assists start-ups and small and medium-sized companies to develop and commercialize technology faster than they could on their own. Monty has extensive sales, operational and leadership experience built on extensive careers with Xerox, IBM and TELUS.